Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

X5 acquired a warehouse complex in the Krasnoyarsk Territory

12/19/25 X5

UAC may place 2.05 trillion additional issue shares

12/19/25 UNAC

Shareholders of X5 approved dividends

12/19/25 X5

Fix Price wants to make a reverse split with a factor of 1000 to 1

12/19/25 FIXR

Ozon-bank enters the market of brokerage services

12/19/25 OZON

VSZ plans to place 2.8 million additional issue shares

12/19/25 VSYD

Renaissance Insurance launches VMI for DOM.RF Bank clients

12/19/25 RENI

VSZ is preparing for a new additional issue

12/19/25 VSYD

Rusagro has started an independent assessment for tax purposes of share transactions

12/19/25 RAGR

Yandex has launched b2b rental of electric bicycles

12/19/25 YDEX